srsd107
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2024 (NCT06116617)
Timeline
Indications
Mechanism of action
- Coagulation factor XIANTISENSE INHIBITOR
F11 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07140523 | Phase 2 | Aug 15, 2025 | Sirius Medicine |
| NCT06116617 | Phase 1 | Jan 31, 2024 | Sirius Medicine |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sirius Medicine | For profit | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1